Ofatumumab-based chemoimmunotherapy effective in CLL Healio An ofatumumab-based chemoimmunotherapy regimen was well tolerated and similarly effective as a rituximab-based regimen in previously untreated patients with chronic lymphocytic leukemia, according to results of a phase 2 study. Only 40% to 50% of ... |
